<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>ChinaCSR.com &#187; factor VIII</title>
	<atom:link href="http://www.chinacsr.com/en/tag/factor-viii/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.chinacsr.com/en</link>
	<description>Corporate Social Responsibility (CSR), Business Intelligence, and Sustainability News for China</description>
	<lastBuildDate>Tue, 07 Feb 2012 06:17:22 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.1</generator>
		<item>
		<title>Bayer Pledges EUR1.5 Million To Hemophilia Treatment Centers In China</title>
		<link>http://www.chinacsr.com/en/2008/12/07/3818-bayer-pledges-eur15-million-to-hemophilia-treatment-centers-in-china/</link>
		<comments>http://www.chinacsr.com/en/2008/12/07/3818-bayer-pledges-eur15-million-to-hemophilia-treatment-centers-in-china/#comments</comments>
		<pubDate>Sun, 07 Dec 2008 02:30:53 +0000</pubDate>
		<dc:creator>editor</dc:creator>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Bayer]]></category>
		<category><![CDATA[bleeding]]></category>
		<category><![CDATA[factor VIII]]></category>
		<category><![CDATA[hematology]]></category>
		<category><![CDATA[hemophilia]]></category>
		<category><![CDATA[hemophilia A]]></category>
		<category><![CDATA[HTC]]></category>
		<category><![CDATA[medical training]]></category>
		<category><![CDATA[nursing]]></category>

		<guid isPermaLink="false">http://www.chinacsr.com/en/?p=3818</guid>
		<description><![CDATA[Pharmaceutical company Bayer Schering Pharmaceuticals has pledged 1.5 million euros to develop hemophilia treatment centers throughout China. Over the next five years, Bayer's donation will fund a variety of necessities and activities, including equipment and supplies, patient programs, educational materials, medical training, and nursing support. The Bayer China Hemophilia Treatment Center Development Project is a [...]]]></description>
		<wfw:commentRss>http://www.chinacsr.com/en/2008/12/07/3818-bayer-pledges-eur15-million-to-hemophilia-treatment-centers-in-china/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

